BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20586973)

  • 1. Relapse and long-acting injectable risperidone: a 1-year mirror image study with a national claims database in Taiwan.
    Su KP; Chang HC; Tsai SJ; Yen FC; Tang CH
    Value Health; 2009; 12 Suppl 3():S118-21. PubMed ID: 20586973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost-consequence analysis of long-acting injectable risperidone in schizophrenia: a one-year mirror-image study with national claim-based database in Taiwan.
    Chang HC; Tang CH; Huang ST; McCrone P; Su KP
    J Psychiatr Res; 2012 Jun; 46(6):751-6. PubMed ID: 22440883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bipolar patients treated with long-acting injectable risperidone in Taiwan: A 1-year mirror-image study using a national claims database.
    Hsieh MH; Chuang PY; Wu CS; Chang CJ; Chung PF; Tang CH
    J Affect Disord; 2017 Aug; 218():327-334. PubMed ID: 28494390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries.
    Peuskens J; Olivares JM; Pecenak J; Tuma I; Bij de Weg H; Eriksson L; Resseler S; Akhras K; Jacobs A
    Curr Med Res Opin; 2010 Mar; 26(3):501-9. PubMed ID: 20014981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.
    Olivares JM; Rodriguez-Martinez A; Burón JA; Alonso-Escolano D; Rodriguez-Morales A;
    Appl Health Econ Health Policy; 2008; 6(1):41-53. PubMed ID: 18774869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care.
    Niaz OS; Haddad PM
    Acta Psychiatr Scand; 2007 Jul; 116(1):36-46. PubMed ID: 17559599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis.
    Carswell C; Wheeler A; Vanderpyl J; Robinson E
    Clin Drug Investig; 2010; 30(11):777-87. PubMed ID: 20712387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone long-acting injection and 1-year rehospitalization rate of schizophrenia patients: A retrospective cohort study.
    Chan HW; Huang CY; Feng WJ; Yen YC
    Psychiatry Clin Neurosci; 2015 Aug; 69(8):497-503. PubMed ID: 25781185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
    Tempest M; Sapin C; Beillat M; Robinson P; Treur M
    J Ment Health Policy Econ; 2015 Dec; 18(4):185-200. PubMed ID: 26729007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of risperidone long acting injection on resource utilization in psychiatric secondary care.
    Taylor M; Currie A; Lloyd K; Price M; Peperell K
    J Psychopharmacol; 2008 Mar; 22(2):128-31. PubMed ID: 18308820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting injectable risperidone and hospital readmission: a mirror-image study using a national claim-based database in Taiwan.
    Chang HC; Tang CH; Tsai SJ; Yen FC; Su KP
    J Clin Psychiatry; 2009 Jan; 70(1):141. PubMed ID: 19238691
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost analysis of risperidone long-acting injection in the treatment of schizophrenia and schizoaffective disorders in Hong Kong: an approach using generalised estimating equations.
    Wu DB; Lee EH; Chung WS; Chow DP; Lee VW; Wong MC; Lee KK
    Psychiatry Res; 2013 Dec; 210(3):745-50. PubMed ID: 24012164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database.
    Voss EA; Ryan PB; Stang PE; Hough D; Alphs L
    Int Clin Psychopharmacol; 2015 May; 30(3):151-7. PubMed ID: 25730525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
    Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
    J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health service utilization and medical costs among patients with schizophrenia receiving long-acting injectable risperidone versus oral risperidone: a nationwide retrospective matched cohort study in Taiwan.
    Fan SJ; Lu N; Chang HC; Tang CH; Huang KC
    Int Clin Psychopharmacol; 2018 Jul; 33(4):204-212. PubMed ID: 29489495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study.
    Barrio P; Batalla A; Castellví P; Hidalgo D; García M; Ortiz A; Grande I; Pons A; Parellada E
    Int Clin Psychopharmacol; 2013 Jul; 28(4):164-70. PubMed ID: 23587986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of long-acting risperidone in Sweden.
    Hensen M; Heeg B; Löthgren M; van Hout B
    Appl Health Econ Health Policy; 2010; 8(5):327-41. PubMed ID: 20804225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain - a cost-effectiveness comparison.
    Dilla T; Möller J; O'Donohoe P; Álvarez M; Sacristán JA; Happich M; Tockhorn A
    BMC Psychiatry; 2014 Dec; 14():298. PubMed ID: 25438678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study.
    De la Gándara J; San Molina L; Rubio G; Rodriguez-Morales A; Hidalgo Borrajo R; Burón JA
    Expert Rev Neurother; 2009 Oct; 9(10):1463-74. PubMed ID: 19831836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.